APC and colorectal cancer: Notably, we identified two FSCs such as APC-F2-1472* and APC-F3-1512*, which produced HLA-A24:02-restricted immunogenic neoantigen peptides (1472SP2 and 1512SP3) with the possible frequencies of 4.9% and 1.5%, respectively, among patients with colorectal cancers (CRCs).